Equest Horse Oral Wormer (POM-VPS)

Product Description

EQUEST Oral Gel contains 18.92 mg/g moxidectin. Also contains 37.84 mg/g benzyl alcohol and 0.24 mg/g disodium edetate as preservatives.

Moxidectin is a second generation macrocyclic lactone of the milbemycin family.

For the treatment of infections caused by moxidectin sensitive strains in horses and ponies:

Large strongyles:

Strongylus vulgaris (adults and arterial stages)

Strongylus edentatus (adults and visceral stages)

Triodontophorus brevicauda (adults)

Triodontophorus serratus (adults)

Triodontophorus tenuicollis (adults)

Small strongyles (adults and intraluminal larval stages) (small redworms):

Cyathostomum spp.

Cylicocyclus spp.

Cylicostephanus spp.

Cylicodontophorus spp.

Gyalocephalus spp.

Ascarids:

Parascaris equorum (adult and larval stages)

Other species:

Pinworm: Oxyuris equi (adult and larval stages)

Stomach worm: Habronema muscae (adults)

Bots: Gasterophilus intestinalis (L2, L3)

Bots: Gasterophilus nasalis (L2, L3)

Threadworm: Strongyloides westeri (adults)

Hairworm: Trichostrongylus axei

EQUEST Oral Gel has a persistent efficacy of 2 weeks against small strongyles. The excretion of small strongyle eggs is suppressed for 90 days.

EQUEST Oral Gel is effective against (developing) intramucosal L4 stages of small strongyles. At eight weeks after treatment early (hypobiotic) EL3 stages of small strongyles are eliminated.

Veterinary advice should be given on appropriate dosing programs and stock management to achieve adequate parasite control and reduce the likelihood of anthelmintic resistance developing. In the event that a product is suspected of being ineffective, the animal owner is advised to seek veterinary advice

View other products in Products »